Circulatory endostatin level and risk of cardiovascular events in patients with end-stage renal disease on hemodialysis

• Hauptverfasser: Jin Sug Kim (Verfasst von), Miji Kim (Verfasst von), Kyung Hwan Jeong (Verfasst von), Ju-Young Moon (Verfasst von), Sang Ho Lee (Verfasst von), Gang Jee Ko (Verfasst von), Dong-Young Lee (Verfasst von), So Young Lee (Verfasst von), Yang Gyun Kim (Verfasst von), Hyeon Seok Hwang (Verfasst von)
• Format: Buch
• Veröffentlicht: The Korean Society of Nephrology, 2024-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background Endostatin is released during extracellular matrix remodeling and is involved in the development of vascular pathology and cardiovascular (CV) disease. However, the role of circulating endostatin as a biomarker of vascular calcification and CV events in patients undergoing hemodialysis (H...